Lipid peroxidation and trace elements in systemic sclerosis

Clinical Rheumatology

Volumn 25, Issue 3, 2006, Pages 320-324

  Tikly, Mohammed ^a   Channa, Kalavati ^b   Theodorou, Penny ^b   Gulumian, Mairam ^b,c  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b National Centre for Occupational Health   (South Africa)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Free radicals; Oxidative stress; Scleroderma; Trace elements

Indexed keywords

COPPER; IRON; LIPID; MALONALDEHYDE; TRACE ELEMENT; ZINC;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD ANALYSIS; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DIET RESTRICTION; DISEASE COURSE; DISEASE DURATION; GAS CHROMATOGRAPHY; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; MEDICAL ASSESSMENT; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SCORING SYSTEM; SYSTEMIC SCLEROSIS;

CASE-CONTROL STUDIES; DISABILITY EVALUATION; FEMALE; HEALTH STATUS; HUMANS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; QUESTIONNAIRES; SCLERODERMA, SYSTEMIC; SKIN; TIME FACTORS; TRACE ELEMENTS;

EID: 33645766009     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-005-0013-4     Document Type: Article

References (27)

1. Herrick AL, Rieley F, Schofield D, Hollis S, Braganza JM, Jayson MIV (1994) Micronutrient antioxidant status in patients with primary Raynaud's phenomenon and systemic sclerosis. J Rheumatol 21:1477-1483
2. Simonini G, Cerinic MM, Generini S, Zoppi M, Anichini M, Cesaretti C et al (1999) Oxidative stress in systemic sclerosis. Mol Cell Biochem 196:85-91
3. Stein CM, Tanner SB, Awad JA, Roberts LJ 2nd, Morrow JD (1996) Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma. Arthritis Rheum 39:1146-1150
4. Belch JJF (1991) Raynaud's phenomenon: Its relevance to scleroderma. Ann Rheum Dis 50:839-845
5. Lau CS, Bridges AB, Muir A, Scott N, Bancroft A, Belch JJF (1992) Further evidence of increased polymorphonuclear activity in patients with Raynaud's phenomenon. Br J Rheumatol 31:375-380
6. Tew MB, Reveille JD, Arnett FC, Friedman AW, McNearney T, Fischbach M et al (2001) Glutathione S-transferase genotypes in systemic sclerosis and their association with clinical manifestations in early disease. Genes Immun 2:236-238
7. Palmer CN, Young V, Ho M, Doney A, Belch JJ (2003) Association of common variation in glutathione S-transferase genes with premature development of cardiovascular disease in patients with systemic sclerosis. Arthritis Rheum 48:854-855
8. Tikly M, Marshall SE, Haldar NA, Gulumian M, Wordsworth P, Welsh KI (2004) Oxygen free radical scavenger enzyme polymorphisms in systemic sclerosis. Free Radic Biol Med 36:1403-1407
9. Lundberg A-C, Åkesson A, Åkesson B (1992) Dietary intake and nutritional status in patients with systemic sclerosis. Ann Rheum Dis 51:1143-1148
10. Herrick AL, Worthington H, Rieley F, Clarke D, Schofield D, Braganza JM et al (1996) Dietary intake of micronutrient antioxidants in relation to blood levels in patients with systemic sclerosis. J Rheumatol 23:650-653
11. Murrell DF (1993) A radical proposal for the pathogenesis of scleroderma. J Am Acad Dermatol 28:78-85
12. Del Maestro RF, Thaw HH, Bjork J, Planker M, Arfors KE (1980) Free radicals as mediators of tissue injury. Acta Physiol Scand 492:43-57
13. Solans R, Motta C, Sola R, La Ville AE, Lima J, Simeon P et al (2000) Abnormalities of erythrocyte membrane fluidity, lipid composition, and lipid peroxidation in systemic sclerosis: Evidence of free radical-mediated injury. Arthritis Rheum 43:894-900
14. Halliwell B, Gutteridge JMC (1999) Free radicals in biology and medicine. Oxford University Press, Oxford
15. Casciola-Rosen L, Wigley F, Rosen A (1997) Scleroderma autoantigens are uniquely fragmented by metal-catalysed oxidation reactions: Implications for pathogenesis. J Exp Med 185:71-79
16. Poli G, Parola M (1997) Oxidative damage and fibrogenesis. Free Radic Biol Med 22:287-305
17. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581-590
18. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TAJ et al (1988) Scleroderma (systemic sclerosis): Classification, subsets, and pathogenesis. J Rheumatol 15:202-205
19. Tager RE, Tikly M (1999) Clinical and laboratory manifestations of systemic sclerosis (scleroderma) in Black South Africans. Rheumatology 38:397-400
20. Clements PJ, Lachenbruch PA, Seibold JR, White B, Weiner S, Martin R et al (1995) Inter- and intra-observer variability of total skin thickness score (modified-Rodnan) in systemic sclerosis (SSc). J Rheumatol 22:1281-1285
21. Fries JF, Spitz P, Kraines RG, Holman HR (1980) Measurement of patient outcome in arthritis. Arthritis Rheum 23:137-145
22. Wong JW, Ebeler SE, Rivkah-Isseroff R, Shibamoto T (1994) Analysis of malondialdehyde in biological samples by capillary gas chromatography. Anal Biochem 220:73-81
23. Jiminez SA, Hitraya E, Varga J (1996) Pathogenesis of scleroderma. Rheum Dis Clin North Am 22:647-674
24. Denton CP, Bunce TD, Dorado MB, Roberts Z, Wilson H, Howell K et al (1999) Probucol improves symptoms and reduces lipoprotein oxidation susceptibility in patients with Raynaud's phenomenon. Rheumatology 38:309-315
25. Herrick AL, Hollis S, Schofield D, Rieley F, Blann A, Griffin K et al (2000) A double-blind placebo-controlled trial of antioxidant therapy in limited cutaneous systemic sclerosis. Clin Exp Rheumatol 18:349-356
26. Leonarduzzi G, Scavazza A, Biasa F, Chiarpotto E, Camandola S, Vogl S et al (1997) The lipid peroxidation endproduct 4-hydroxy-2,3-nonenal up-regulates transforming growth factor-b1 expression in the macrophage lineage: A link between oxidative injury and fibrosclerosis. FASEB J 11:851-857
27. Gries CL, Scott ML (1972) Pathology of selenium deficiency in the chick. J Nutr 102:1287-1296